Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Prolopa 125


Contraindicated
Visceral and skeletal malformations in rabbits

Contraindicated
Prolopa 125 :
Type TAU
Originator Madopar 125*
Agent Rahbani
Distributor Rahbani
Laboratory Roche
Manufacturer F. Hoffmann La Roche Ltd
Manufacturing Type G
Origin Switzerland
ATC N04BA02

Your comment will appear shortly after approval

Prolopa 125 :

Revision Date : 01/12/2012


Effect Frequency
Addictive behaviour Not known
Amenorrhoea secondary Very rare
Anorexia Uncommon
Arrhythmia Uncommon
Athetotic movements Rare
Blood alkaline phosphatase increased Uncommon
Blood urea nitrogen (BUN) increased Uncommon
Cephalea Uncommon
Choreiform movements Rare
Compulsive behaviour Not known
Daytime drowsiness Very rare
Decreased appetite Uncommon
Depression Not known
Diarrhoea (Diarrhea) Uncommon
Dry mouth (Xerostomia) Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very rare
Gamma-GT increased Uncommon
Haemolytic anemia Rare
Hypersexuality Not known
Impulse-control disorder Not known
Leucopenia (Leukopenia) Rare
Libido increased Not known
Movements involuntary Rare
Nausea Uncommon
Orthostatic hypotension Uncommon
Pathological gambling Not known
Platelet count decreased transient Rare
Prothrombin time shortened Rare
Pruritus Rare
SGOT increased Uncommon
SGPT increased Uncommon
Skin rash Rare
Somnolence Common
Sudden onset of sleep Common
Suicidal ideation Not known
Vomiting Uncommon

Different Units By MoH Code

Prolopa 125  MoH 2020118 :
Form Tablet, Dispersible
Package Size Box of 100
Strength 25mg/100mg
Stratum N/A
NSSF ✘
Quarantine ✘


Price Comparison

● Country: Belgium
● Package Size: 100
● Public Price: 20.13 EUR ( 1,950,113.88 LBP )
● Pack size unit used: 100
● Cost/Unit: 0,2013 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info